Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620000241932
Ethics application status
Approved
Date submitted
16/01/2020
Date registered
26/02/2020
Date last updated
6/10/2022
Date data sharing statement initially provided
26/02/2020
Date results provided
6/10/2022
Type of registration
Prospectively registered

Titles & IDs
Public title
Study protocol: It takes a village: Development and testing of 'Village' a communication application for young people who are experiencing low mood and suicidal ideation to obtain real-time support from a network of family and friends
Scientific title
Assessing the acceptability of Village - a communication app for supporting young people with low mood and suicidal ideation
Secondary ID [1] 300140 0
Nil
Universal Trial Number (UTN)
U1111-1245-7131
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
suicide
 315865 0
Condition category
Condition code
Mental Health 314149 314149 0 0
Suicide

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Village is an innovative communication application (app) co-designed with young people and families/whanau that aims to help young people obtain regular and timely support from a network of ‘buddies’ (family/whanau or peers) who are in turn educated and supported via information modules within the app to respond appropriately. The app is independently used without external therapist support. Young people will be encouraged to complete a daily 'check in' regarding their mood (quick mood rating using a sliding scale) and they will be encouraged to identify and use a range of self-management strategies about which they will be educated while using the app (within a self-help module). They will also be contacted by their buddies on a daily-weekly basis, so that they can let them know how they are doing and what help they need. Buddies are educated in how to respond to young people using a combination of validation and appropriately supportive messages. They are also provided with additional education about wellbeing, self-harm and common mental health issues such as anxiety and depression. The app consists of modules for mood rating, communication with buddies and education about common mental health problems, self-help strategies and communication strategies (the last one being for buddies only). Education modules were developed by an experienced child psychiatrist and modified during co-design sessions with a range of young people and adults.

The app will be downloaded onto participants' smartphones and used in a therapist- unsupported manner by them as many times as they wish over a 4 week period (no specific frequency). If concerning messages (regarding risk/suicidal ideation) within the app are detected by inbuilt AI software, participants may be contacted by a real-life telephone support service (Youthline). Frequency, duration and components of app use will be evaluated via app analytics at the end of the trial.

Link to explainer video: https://www.youtube.com/watch?v=hokq9F3ecYs
Intervention code [1] 316556 0
Treatment: Other
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 322534 0
Acceptability of VIllage app with young people and support people (buddies) using qaulitative interviews and the uMARS scale
Timepoint [1] 322534 0
4 weeks following the start of the intervention
Secondary outcome [1] 378853 0
Change in level of suicidal ideation measured via the SIQ-JR scale
Timepoint [1] 378853 0
4 and 12 weeks following start of intervention
Secondary outcome [2] 378854 0
Change in level of depression measured via the PHQ-A scale
Timepoint [2] 378854 0
4 and 12 weeks following start of intervention
Secondary outcome [3] 378855 0
Change in level of functioning using the WHODAS 2.0 scale (used instead of the previously nominated CAFAS scale) .
Timepoint [3] 378855 0
4 and 12 weeks following start of intervention

Eligibility
Key inclusion criteria
Participants will include 20 young people aged 13-18 years of any gender who have presented to acute or community mental health services with suicidal ideation (frequent or with a plan), a suicide attempt or both within the past 4 weeks. Eligible participants will have access to an iPhone or an-droid mobile telephone, reside in the ADHB catchment area (i.e. Auckland), be undertaking any kind of routine care (including psychotherapy and medication), speak adequate English and be able to provide informed consent.
Minimum age
13 Years
Maximum age
18 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Participants who do not meet all the inclusion criteria will be excluded.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Not applicable
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Not applicable
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Quantitative data from questionnaires will be analysed using Microsoft Excel and SPSS (Statistical Package for Social Sciences). Analyses will include basic descriptive statistics (e.g. changes in scores on validated scales, demo-graphic characteristics of the sample and aspects of app use). Pai-red t Tests and McNemar’s chi-square tests will be used to assess the statistical significance of changes in scores over time. A p-value of <0.05 will be taken to indicate statistical significance and 95% confidence intervals will be used to establish the extent of any difference between pre and post measures.

Qualitative data from semi-structured interviews will be analysed using Braun and Clarke’s method of thematic analysis (REF) with collated text being analysed to identify emerging themes, 30% being cross-coded by a second researcher and consensus reached by adjudication.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/06/2020
Actual
1/11/2020
Date of last participant enrolment
Anticipated
1/12/2020
Actual
28/02/2021
Date of last data collection
Anticipated
1/03/2021
Actual
31/03/2021
Sample size
Target
20
Accrual to date
Final
27
Recruitment outside Australia
Country [1] 22234 0
New Zealand
State/province [1] 22234 0
Auckland

Funding & Sponsors
Funding source category [1] 304576 0
Charities/Societies/Foundations
Name [1] 304576 0
Starship Foundation
Country [1] 304576 0
New Zealand
Primary sponsor type
Charities/Societies/Foundations
Name
Starship Foundation
Address
Level 15 Support Block, Auckland Hospital, 2 Park Road, Grafton, Auckland 1142, New Zealand
Country
New Zealand
Secondary sponsor category [1] 305022 0
None
Name [1] 305022 0
Address [1] 305022 0
Country [1] 305022 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 305002 0
Health and Disability Ethics Committee (HDEC)
Ethics committee address [1] 305002 0
Ethics committee country [1] 305002 0
New Zealand
Date submitted for ethics approval [1] 305002 0
15/02/2020
Approval date [1] 305002 0
30/05/2020
Ethics approval number [1] 305002 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 98926 0
Dr Hiran Thabrew
Address 98926 0
Department of Psychological Medicine, University of Auckland
Level 12 Support Block
Auckland Hospital
2 Park Road
Grafton
Auckland 1142
New Zealand
Country 98926 0
New Zealand
Phone 98926 0
+64 21402055
Fax 98926 0
Email 98926 0
[email protected]
Contact person for public queries
Name 98927 0
Hiran Thabrew
Address 98927 0
Department of Psychological Medicine, University of Auckland
Level 12 Support Block
Auckland Hospital
2 Park Road
Grafton
Auckland 1142
New Zealand
Country 98927 0
New Zealand
Phone 98927 0
+64 21402055
Fax 98927 0
Email 98927 0
[email protected]
Contact person for scientific queries
Name 98928 0
Hiran Thabrew
Address 98928 0
Department of Psychological Medicine, University of Auckland
Level 12 Support Block
Auckland Hospital
2 Park Road
Grafton
Auckland 1142
New Zealand
Country 98928 0
New Zealand
Phone 98928 0
+64 21402055
Fax 98928 0
Email 98928 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Not in study protocol. No resourcing available to provide this facility.


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.